EICHOR
● Active Not Recruiting
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Condition: Obesity · Overweight · Chronic Low Back Pain (CLBP) · Sponsor: Eli Lilly and Company
About this study
The main purpose of this study is to evaluate the efficacy and safety of retatrutide in relieving chronic low back pain in participants who have obesity or overweight. Participation in the study will last about 80 weeks.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (40)
| MD First Research - Chandler | Chandler, Arizona, United States | — |
| Tucson Orthopaedic Institute - North Wyatt Drive | Tucson, Arizona, United States | — |
| Ark Clinical Research - Fountain Valley | Fountain Valley, California, United States | — |
| St Joseph Heritage Healthcare | Fullerton, California, United States | — |
| Clinical Research Institute | Los Angeles, California, United States | — |
| Artemis Institute for Clinical Research | San Diego, California, United States | — |
| Alpine Clinical Research Center | Boulder, Colorado, United States | — |
| K2 Medical Research - Daytona Beach | Daytona Beach, Florida, United States | — |
| Flourish Research - Miami, LLC | Miami, Florida, United States | — |
| IMA Clinical Research St. Petersburg | St. Petersburg, Florida, United States | — |
| Care Access - Tampa | Tampa, Florida, United States | — |
| Charter Research - Lady Lake | The Villages, Florida, United States | — |
+ 28 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07035093